El año pasado, Amphastar Pharmaceuticals Inc generó 229.65M USD en su segmento con mejor rendimiento, Other products. United States realizó la mayor aportación, representando 681.42M USD el año pasado. Para el último trimestre, Amphastar Pharmaceuticals Inc reportó unos ingresos de 40.41M USD para el periodo finalizado el 2024-09-30, procedentes del segmento con mejor rendimiento, BAQSIMI. United States aportó los mayores ingresos, alcanzando los 172.34M USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

Other products

BAQSIMI

Primatene Mist

Epinephrine

Glucagon

Lidocaone

Other Revenues

Phytonadione

Enoxaparina

Naloxone

Other finished pharmaceutical products

Primatene® Mist

BAQSIMI NEB

Medroxyprogesterone

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Other products

229.65M(31.90%)

145.03M(19.81%)

--(--)

BAQSIMI

185.36M(25.75%)

126.90M(17.34%)

--(--)

Primatene Mist

108.67M(15.10%)

102.01M(13.94%)

89.32M(12.41%)

--(--)

Epinephrine

70.64M(9.81%)

94.09M(12.85%)

81.65M(11.35%)

74.20M(15.25%)

57.53M(13.71%)

23.80M(7.18%)

13.88M(4.60%)

Glucagon

69.08M(9.60%)

108.32M(14.80%)

113.68M(15.80%)

55.32M(11.37%)

47.64M(11.35%)

--(--)

Lidocaone

56.48M(7.85%)

55.85M(7.63%)

58.16M(8.08%)

52.54M(10.80%)

44.41M(10.59%)

41.11M(12.41%)

46.01M(15.24%)

Other Revenues

--(--)

19.15M(2.62%)

--(--)

Phytonadione

--(--)

43.17M(5.90%)

44.94M(6.25%)

49.50M(10.17%)

45.50M(10.84%)

42.65M(12.87%)

45.79M(15.16%)

Enoxaparina

--(--)

21.71M(2.97%)

31.53M(4.38%)

34.95M(7.18%)

35.96M(8.57%)

48.68M(14.69%)

42.70M(14.14%)

Naloxone

--(--)

15.73M(2.15%)

19.00M(2.64%)

26.27M(5.40%)

27.54M(6.56%)

33.42M(10.08%)

34.76M(11.51%)

Other finished pharmaceutical products

--(--)

140.82M(19.57%)

109.41M(22.49%)

87.88M(20.94%)

89.99M(27.16%)

72.94M(24.15%)

Primatene® Mist

--(--)

89.32M(12.41%)

84.31M(17.33%)

73.11M(17.43%)

51.73M(15.61%)

18.07M(5.98%)

BAQSIMI NEB

--(--)

51.16M(7.11%)

--(--)

Medroxyprogesterone

--(--)

27.85M(9.22%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

France

China

United Kingdom

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

United States

681.42M(94.66%)

707.68M(96.68%)

635.19M(98.57%)

486.83M(97.56%)

419.87M(95.91%)

333.09M(95.21%)

304.90M(94.58%)

279.12M(94.72%)

France

35.28M(4.90%)

19.95M(2.73%)

4.70M(0.73%)

7.46M(1.49%)

11.88M(2.71%)

13.59M(3.89%)

15.98M(4.96%)

15.54M(5.28%)

China

3.18M(0.44%)

4.34M(0.59%)

4.50M(0.70%)

4.70M(0.94%)

6.02M(1.38%)

3.16M(0.90%)

1.48M(0.46%)

--(--)

United Kingdom

--(--)